SCHEMBL3772865

SCHEMBL3772865

O=C(c1ccc(C2CCCCC2)cc1)N1CC(N2CCN(c3nccs3)CC2)C1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 2/20 0.54
MGLL Q99685 6/20 0.48
L3MBTL3 Q96JM7 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
HPGD P15428 1/20 0.43
GRM5 P41594 1/20 0.43
GRM1 Q13255 1/20 0.43
KDM4E B2RXH2 2/20 0.42
RECQL P46063 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
SCD O00767 1/20 0.41
NAMPT P43490 1/20 0.40
FAAH O00519 1/20 0.40
MBTD1 Q05BQ5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL910870 0.86 MGLL (0.55) SLC6A7MGLLL3MBTL3L3MBTL1KDM4E
SCHEMBL3765832 0.83 SLC6A7 (0.79) SLC6A7MGLLL3MBTL3L3MBTL1KDM4E
SCHEMBL3771443 0.82 SLC6A7 (0.77) SLC6A7MGLLL3MBTL3L3MBTL1HPGD
SCHEMBL3777040 0.80 SLC6A7 (0.64) SLC6A7MGLLL3MBTL3L3MBTL1KDM4E
SCHEMBL3771927 0.79 SMN1; SMN2 (0.56) SLC6A7MGLLHPGDKDM4ECTSB
SCHEMBL3775050 0.79 SLC6A7 (0.46) SLC6A7MGLLL3MBTL3L3MBTL1MBTD1
SCHEMBL3765848 0.78 SLC6A7 (0.58) SLC6A7MGLLL3MBTL3L3MBTL1KDM4E
SCHEMBL3779599 0.78 SLC6A7 (0.58) SLC6A7MGLLL3MBTL3L3MBTL1KDM4E
SCHEMBL3783323 0.78 PROKR1 (0.58) SLC6A7MGLLL3MBTL3L3MBTL1KDM4E
SCHEMBL6843132 0.77 L3MBTL3 (0.54) SLC6A7L3MBTL3L3MBTL1KDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421852-B9 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITOR JANSSEN PHARMACEUTICA NV (BE) 2015-07-01 EP disclosed
US-8815839-B2 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2014-08-26 US disclosed
EP-2421852-B1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITOR JANSSEN PHARMACEUTICA NV (BE) 2014-05-21 EP disclosed
US-20130184251-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2013-07-18 US disclosed
US-8415341-B2 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2013-04-09 US disclosed
US-20100324015-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324015-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS MGLL, PNLIP, LIPC SLC6A7 3678/4885MGLL 1/4885L3MBTL3 1571/4885
US-20130184251-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS MGLL, PNLIP, LIPC SLC6A7 3678/4885MGLL 1/4885L3MBTL3 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.